Onkar V. Khullar

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).”.

A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4651

N/A

0DataRank · unranked

11 citations

Michelle Weitz, Michael K. Gibson, Lakshmi Rajdev, Onkar V. Khullar, Steven H. Lin +13 more

Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs

CHEST Journal(2021)10.1016/j.chest.2021.11.004

N/A

0DataRank · unranked

15 citations

William A. Stokes, Manali Rupji, Yuan Liu, Onkar V. Khullar, Nikhil Sebastian +9 more

A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in—A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4064

N/A

0DataRank · unranked

13 citations

Michelle Weitz, Paul J. Catalano, Michael K. Gibson, Lakshmi Rajdev, Onkar V. Khullar +15 more

A phase II/III study of peri-operative nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of the neoadjuvant pathologic complete response (pCR) rate (ECOG-ACRIN EA2174).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.4000

N/A

0DataRank · unranked

23 citations

Noah Graham, Michael K. Gibson, Lakshmi Rajdev, Anuradha Chakravarthy, Onkar V. Khullar +13 more

Decreasing Complications After Ivor‐Lewis Esophagectomy: Is a Totally Minimally Invasive Approach the Solution?

Journal of Surgical Oncology(2025)10.1002/jso.70011

N/A

0DataRank · unranked

0 citations

Caitlin Sok, Pranay S. Ajay, Yichun Cao, Alicia M. Bonanno, Kenneth Cardona +9 more